A robust capillary liquid chromatography/tandem mass spectrometry method for quantitation of neuromodulatory endocannabinoids

Rapid Communications in Mass Spectrometry

Volumn 29, Issue 20, 2015, Pages 1889-1897

  Qi, Ming ^a   Morena, Maria ^b,c   Vecchiarelli, Haley A ^b,c   Hill, Matthew N ^b,c   Schriemer, David C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SOLVENT EXTRACTION; TISSUE ENGINEERING;

2-ARACHIDONOYL GLYCEROLS; ANANDAMIDE; CAPILLARY LIQUID CHROMATOGRAPHY; CENTRAL NERVOUS SYSTEMS; ENDOCANNABINOID; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; MOLECULAR MECHANISM; SUPPORT PROGRAMS; TISSUE SAMPLES;

TISSUE;

2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; AMIDE; ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID;

ANIMAL; BRAIN CHEMISTRY; EVALUATION STUDY; LIQUID CHROMATOGRAPHY; PROCEDURES; RAT; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY;

ANIMALS; ARACHIDONIC ACIDS; BRAIN CHEMISTRY; CHROMATOGRAPHY, LIQUID; ENDOCANNABINOIDS; GLYCERIDES; NEUROTRANSMITTER AGENTS; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY;

EID: 84942422322     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.7277     Document Type: Article

References (33)

1. B. B. Gorzalka, M. N. Hill, C. J. Hillard,. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci. Biobehav. Rev. 2008, 32, 1152.
2. V. Micale, V. Di Marzo, A. Sulcova, C. T. Wotjak, F. Drago,. Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacol. Ther. 2013, 138, 18.
3. P. Anand, G. Whiteside, C. J. Fowler, A. G. Hohmann,. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain. Brain Res. Rev. 2009, 60, 255.
4. M. N. Hill, S. A. Kumar, S. B. Filipski, M. Iverson, K. L. Stuhr, J. M. Keith, B. F. Cravatt, C. J. Hillard, S. Chattarji, B. S. McEwen,. Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol. Psychiatry 2013, 18, 1125.
5. T. F. Freund, I. Katona, D. Piomelli,. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 2003, 83, 1017.
6. D. Piomelli,. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 2003, 4, 873.
7. I. Matias, V. Di Marzo,. Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance. J. Endocrinol. Invest. 2006, 29, 15.
8. F. Desarnaud, H. Cadas, D. Piomelli,. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J. Biol. Chem. 1995, 270, 6030.
9. T. P. Dinh, D. Carpenter, F. M. Leslie, T. F. Freund, I. Katona, S. L. Sensi, S. Kathuria, D. Piomelli,. Brain monoglyceride lipase participating in endocannabinoid inactivation (2002, 99, 10819). Proc. Natl. Acad. Sci. USA. 2002, 99, 13961.
10. M. N. Hill, R. J. McLaughlin, B. Bingham, L. Shrestha, T. T. Lee, J. M. Gray, C. J. Hillard, B. B. Gorzalka, V. Viau,. Endogenous cannabinoid signaling is essential for stress adaptation. Proc. Natl. Acad. Sci. USA. 2010, 107, 9406.
11. A. A. Zoerner, F. M. Gutzki, S. Batkai, M. May, C. Rakers, S. Engeli, J. Jordan, D. Tsikas,. Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective. Biochim. Biophys. Acta 2011, 1811, 706.
12. M. W. Buczynski, L. H. Parsons,. Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls. Br. J. Pharmacol. 2010, 160, 423.
13. Y. Arai, T. Fukushima, M. Shirao, X. J. Yang, K. Imai,. Sensitive determination of anandamide in rat brain utilizing a coupled-column HPLC with fluorimetric detection. Biomed. Chromatogr. 2000, 14, 118.
14. A. Schmidt, K. Brune, B. Hinz,. Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography. Biomed. Chromatogr. 2006, 20, 336.
15. W. A. Devane, L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, R. Mechoulam,. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258, 1946.
16. L. Hanus, A. Gopher, S. Almog, R. Mechoulam,. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J. Med. Chem. 1993, 36, 3032.
17. M. Sergi, N. Battista, C. Montesano, R. Curini, M. Maccarrone, D. Compagnone,. Determination of the two major endocannabinoids in human plasma by mu-SPE followed by HPLC-MS/MS. Anal. Bioanal. Chem. 2013, 405, 785.
18. A. A. Zoerner, S. Batkai, M. T. Suchy, F. M. Gutzki, S. Engeli, J. Jordan, D. Tsikas,. Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012, (883/884), 161.
19. M. G. Balvers, K. C. Verhoeckx, R. F. Witkamp,. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 1583.
20. D. Richardson, C. A. Ortori, V. Chapman, D. A. Kendall, D. A. Barrett,. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal. Biochem. 2007, 360, 216.
21. M. Lehtonen, M. Storvik, H. Malinen, P. Hyytia, M. Lakso, S. Auriola, G. Wong, J. C. Callaway,. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011, 879, 677.
22. S. Gouveia-Figueira, M. L. Nording,. Development and validation of a sensitive UPLC-ESI-MS/MS method for the simultaneous quantification of 15 endocannabinoids and related compounds in milk and other biofluids. Anal. Chem. 2014, 86, 1186.
23. P. C. Schmid, R. J. Krebsbach, S. R. Perry, T. M. Dettmer, J. L. Maasson, H. H. Schmid,. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 1995, 375, 117.
24. P. J. Kingsley, L. J. Marnett,. LC-MS-MS analysis of neutral eicosanoids. Methods Enzymol. 2007, 433, 91.
25. K. Ahn, S. E. Smith, M. B. Liimatta, D. Beidler, N. Sadagopan, D. T. Dudley, T. Young, P. Wren, Y. Zhang, S. Swaney, K. Van Becelaere, J. L. Blankman, D. K. Nomura, S. N. Bhattachar, C. Stiff, T. K. Nomanbhoy, E. Weerapana, D. S. Johnson, B. F. Cravatt,. Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain. J. Pharmacol. Exp. Ther. 2011, 338, 114.
26. The Rat Brain in Stereotaxic Coordinates, (5th edn.), (Eds:, G. Paxinos, C. Watson,). Elsevier, Burlington, MA, 2005.
27. + coordination tandem mass spectrometry. Anal. Biochem. 2003, 314, 8.
28. J. Palandra, J. Prusakiewicz, J. S. Ozer, Y. Zhang, T. G. Heath,. Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 2052.
29. J. Adams, M. L. Gross,. Tandem mass spectrometry for collisional activation of alkali-metal-cationized fatty acids-a method for determining double-bond location. Anal. Chem. 1987, 59, 1576.
30. F. F. Hsu, J. Turk,. Distinction among isomeric unsaturated fatty acids as lithiated adducts by electrospray ionization mass spectrometry using low energy collisionally activated dissociation on a triple stage quadrupole instrument. J. Am. Soc. Mass Spectrom. 1999, 10, 600.
31. G. L. Li, H. Winter, R. Arends, G. W. Jay, V. Le, T. Young, J. P. Huggins,. Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects. Br. J. Clin. Pharmacol. 2012, 73, 706.
32. R. J. Henry, D. M. Kerr, D. P. Finn, M. Roche,. FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampus. J. Neuroimmunol. 2014, 276, 126.
33. J. W. Chang, M. J. Niphakis, K. M. Lum, A. B. Cognetta 3rd, C. Wang, M. L. Matthews, S. Niessen, M. W. Buczynski, L. H. Parsons, B. F. Cravatt,. Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates. Chem. Biol. 2012, 19, 579.